Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Staphylococcus epidermidis strategies to avoid killing by human neutrophils
32 TakatoriNHiyamaASakaiDKatohHSatoMWatanabeM
Lancet 2023
Transcription factor STAT3 as a novel molecular target for cancer prevention
Heres how the value chain of Pharmaceutical players look like - Intermediates API (Generic/Specialty) Formulations (Domestic/ROW/USA) Patient Then there are these CDMO players who serves innovator pharma companies NCE/Innovation drug discovery, biosimilars, novel biologics and then Domestic Branded India prescription-driven, doctor-detailing led businesses So with this background lets get on and dive deeper on the themes in this space that have performed strongly and the tailwinds that are there in each of the themes 1) Aarti Drugs - The Aarti Drugs story over the last three years can be summed up in this single chart The company has delivered consistent positive volume growth every single year for the last 5 years: 5%, 11%, 10%, 7% respectively from FY22 to FY26
Some 5mg participants lost 20% or more
US$ 24.43
US$ 20.78
US$ 26.69
US$ 21.60
US$ 22.46
US$ 25.90
